טוען...
Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus
AIMS/INTRODUCTION: An initial 26‐week, randomized, open‐label study compared the efficacy and safety of exenatide 10 mcg twice daily with exenatide 2 mg once weekly in Asian patients with type 2 diabetes who experienced inadequate glycemic control with oral antidiabetes medications. The aim of this...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley-Blackwell
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4019273/ https://ncbi.nlm.nih.gov/pubmed/24843650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12000 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|